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Background/Aims: Complementary medicines, including 
herbal preparations and nutritional supplements, are widely 
used without prescriptions. As a result, there has been grow-
ing interest in the risk of hepatotoxicity with these agents. It 
is difﬁ  cult to determine causal relationships between these 
herbal preparations and hepatotoxicity. We report on 25 
patients diagnosed with toxic hepatitis following ingestion 
of Polygonum multiflorum Thunb. Methods: Twenty-five 
patients (median age, 48 years [24 to 65 years]; M:F=18:7) 
with suspected P. multiflorum Thunb-induced liver injury 
were admitted to our hospital between 2007 and 2009. We 
analyzed clinical and histological data, including the types 
and the duration of P. multiﬂ  orum Thunb intake and the du-
ration of hospital care. We also determined the type of liver 
injury using the R ratio (serum activity of ALT/serum activ-
ity of ALP). Results: The types of complementary medicine 
used included tea (n=16), liquor (n=5), tea and liquor (n=2), 
powder (n=1), and honeyed pudding (n=1). The most com-
mon presenting sign was jaundice (76%), and 18 patients 
(72%) had evidence of hepatocellular liver injury. Histologi-
cal ﬁ  ndings were consistent with acute hepatitis in all cases 
(n=10) for which liver biopsy was performed. Twenty-three 
patients (91.6%) recovered with conservative management, 
1 patient (4%) had a liver transplant, and 1 patient (4%) died 
of hepatic failure. Conclusions: In our cases, we found that 
P. multiﬂ  orum Thunb could be hepatotoxic and could lead to 
severe drug-induced liver injury, and even death. (Gut Liver 
2011;5:493-499)
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INTRODUCTION
Drug induced liver injury (DILI) is an adverse drug reac-
tion associated with commonly used drugs, mostly nonsteroi-
dal anti-inflammatory drugs, paracetamol, and antimicrobial 
agents.
1 In some reports, more than a 1,000 drugs of the modern 
pharmacopoeia can induce liver injury with different clinical 
presentations.
2,3 Diagnosis of DILI is difficult and data on the 
incidence of DILI cases are extremely variable due to a lack of 
internationally accepted criteria of DILI.
4-6 DILI associated with 
herbal preparations is not uncommon in Western and Asian 
societies.
7-11 DILI caused by a single plant taken as a nutritional 
supplement has been occasionally reported. Whereas, it has not 
been reported to be caused by herbal preparations consisting of 
multiple plants.
12,13 Many people understand that natural botan-
icals are beneficial but not harmful. However, natural botanicals 
can be also causes of DILI,
13 because herbal medicine induced 
liver injury is caused by its metabolites as well as natural bo-
tanicals. 
Polygonum multiflorum Thunb is one of Chinese herbs, which 
has generated a lot of interests. It is the root of P. multiplorum, 
a member of Polygonaceae. The root tuber of this plant was re-
corded in herbal Kaibao Bencao published by the imperial court 
of the Song Dynasty (973-974 A.D.).
14 P. multiflorum Thunb is 
consumed either in its raw form, or as an extract after process-
ing. It is generally referred to as Shou Wu Pian or Ho-Shou-Wu. 
The most well-known products associated with hepatotoxicity 
of P. multiflorum are Shou-Wu-Pian and Shen-Min, which are 
usually consumed as an anti-aging product, or as a tonic for 
dizziness with tinnitus. They also appear to be efficacious in the 
treatment of premature greying of hair, lumbago, spermator-494  Gut and Liver, Vol. 5, No. 4, December 2011
rhea, leucorrhea and constipation.
15,16 Thus far, 6 cases of acute 
hepatitis induced by P. multiflorum Thunb, a main constituent 
of Sho-Wu-Pian,
14,15,17-19 have been reported worldwide, includ-
ing one case in Korea.
20
We describe 25 cases of hepatitis caused by P. multiflorum 
Thunb with analyzing the results of their clinical course, labora-
tory and histological findings. 
MATERIALS AND METHODS
This study entailed collection and analyses of clinical infor-
mation using questionnaires and laboratory results in 25 pa-
tients diagnosed with P. multiflorum Thunb-induced hepatitis, 
among patients diagnosed with toxic hepatitis in the Gastro-
enterology Department of the Gyeongsang National University 
Hospital between 2007 and 2009. The diagnosis was established 
on the basis of drug history before the symptomatic period, 
physical examination on admission and acute hepatitis accord-
ing to laboratory investigations or histological findings. More 
than 2 well-experienced gastroenterologists in the field of toxic 
hepatitis were highly suspicious of DILI and excluded other pos-
sible causes of hepatitis such as HAV, HBV, HCV, HEV, EBV, 
CMV, HSV, autoimmune hepatitis, Wilson’s disease and alcohol 
in our cases. When we initiated the study, there was a mass 
outbreak of DILI in the same region, which was thought to be 
possibly caused by P. multiflorum Thunb. Then we conducted 
a systematic questionnaire survey to assess the likelihood of P. 
multiflorum Thunb-induced liver injury with a good protocol. 
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1 57/M 30 Jaundice Fever, arthralgia,
 thrombocytopenia
8 853/173/28.1/2.57 Mixed 13 Death
2 49/M 90 Jaundice Fever, skin rash,
 thrombocytopenia
9 1,235/465/32.9/1.12 Mixed 43 Recovery
3 46/M 2 Jaundice No 9 1,287/146/19.7/1.1 Hepatocellular 36 Recovery
4 47/F 60 Jaundice Fever, arthralgia,
 pancytopenia
8 1,947/218/30.4/0.94 Hepatocellular 47 Recovery
5 34/M 30 Jaundice Fever, pancytopenia 9 1,452/111/25.3/1.27 Hepatocellular 37 Recovery
6 58/M 35 Jaundice No 9 1,898/134/13.7/1.04 Hepatocellular 15 Recovery
7 59/M 30 Abdominal pain No 8 1,245/155/1.6/1.13 Hepatocellular 15 Recovery
8 54/F 4 Jaundice No 7 1,752/286/8.4/1.04 Hepatocellular 29 Recovery
9 46/F 30 Jaundice No 8 1,804/81/6.2/1.01 Hepatocellular 18 Recovery
10 62/M 90 Jaundice Fever 9 1,174/175/9.2/14.98* Hepatocellular 36 Recovery
11 63/F 30 Fatigue No 9 943/137/4.2/0.88 Hepatocellular   8 Recovery
12 24/M 60 Jaundice No 7 1,652/140/31.9/9.56 Hepatocellular 28 LT
13 45/M 20 Abdominal pain No 8 271/164/2.9/1.08 Mixed 18 Recovery
14 41/M 30 Jaundice No 7 520/143/9.9/0.98 Mixed 14 Recovery
15 44/M 7 Jaundice No 9 1,077/197/15/0.98 Hepatocellular 17 Recovery
16 65/M 10 Jaundice No 8 1,107/197/21.9/1.04 Hepatocellular 10 Recovery
17 53/M 180 Jaundice No 6 1,227/370/33.2/1.11 Mixed   9 Recovery
18 42/F 10 No symptom No 8 500/181/1.6/0.95 Mixed   0 Recovery
19 61/M 1 Myalgia No 10 818/109/1.77/0.91 Hepatocellular   3 Recovery
20 42/M 120 Jaundice No 7 1,677/93/15.8/1.03 Hepatocellular 21 Recovery
21 48/F 3 Jaundice No 8 1,142/145/15.9/1.0 Hepatocellular 16 Recovery
22 54/F 180 Jaundice Skin rash 6 1,519/187/11.7/0.92 Hepatocellular 21 Recovery
23 61/M 60 Jaundice No 10 885/224/21.2/0.98 Mixed 14 Recovery
24 45/M 30 Fatigue No 9 1,400/125/2.04/1.16 Hepatocellular   8 Recovery
25 42/M 60 Jaundice Eosinophilia 8 1,706/147/26.3/1.08 Hepatocellular 14 Recovery
CIOMS, Council for International Organizations of Medical Sciences; RUCAM, Roussel Uclaf Causality Assessment Method; ALP, alkaline phos-
phatase; ALT, alanine aminotransferase; TB, total bilirubin; PT, prothrombin time; INR, international normalized ratio; LT, liver transplantation.
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We were consistently meticulous in history-taking and assess-
ment to rule out other possible causes of liver injury. Most of 
the patients were followed-up at least for 6 months after recov-
ery from the disease. We conducted analyses based on sex, age, 
clinical manifestations on admission, laboratory data, duration 
of intake, the time of symptom onset, histological findings and 
clinical course. We also estimated the Roussel Uclaf Causality 
Assessment Method (RUCAM) scale to enhance the reliability 
of diagnosis of DILI. Sixty-four percents of the patients lived in 
single city, Sacheon and 15 cases (60%) of them occurred be-
tween May and November 2007.
RESULTS
The patient characteristics and outcomes were summarized in 
Table 1.
1. Gender and age
The patients consisted of 18 men and 7 women. Their age 
ranged between 24 and 65, with a median age of 48.
2. Clinical manifestations on admission
The main clinical manifestations leading to patient admis-
sions were as follows: jaundice (19 cases), abdominal pain with 
nausea (2 cases), fatigue (2 cases), and myalgia (1 case), and no 
symptom (1 case). During the hospitalization 5 patients devel-
oped fever, arthralgia in 2 patients, eosinophilia in 1 patient and 
skin rash in 2 patients.
3. Type and duration of intake, and onset time of symptoms
Sixteen patients drank tea boiled with the root of the P. mul-
tiflorum Thunb, 5 patients drank liquor made of the plant, 2 
patients drank tea and liquor soaked out from it, 1 patient took 
honey mixed with ground powder of its root, and 1 patient took 
the ground powder of its root. The median duration of intake 
was 30 days (range, 1 to 180 days). Toxic hepatitis developed in 
1 patient who had ingested it for 1 day and another 1 patient 
for 2 days. The interval from intake to the onset of symptoms 
ranged between 1 and 120 days, with a mean of 31 days.
4. Laboratory ﬁ  ndings
At the time of admission 24 patients showed markedly el-
evated alanine aminotransferase (ALT; >10×UNL) and 9 had 
remarkably elevated total bilirubin (>20 mg/dL). In patients who 
presented to our hospital via private hospitals, we included their 
initial laboratory data in private hospitals. Eighteen patients 
had hepatocelluar liver injury and the remainder of the patients 
including 1 alcoholics had mixed pattern liver injury according 
to laboratory data. Four patients had prolonged prothrombin 
time (international normalized ratio [INR] >1.2) and 2 of them 
had an INR of 9.56 and 14.98, respectively. Serologic markers 
were all negative: HBsAg(-), IgM Anti-HBc(-), IgM Anti-HAV(-), 
Anti-HCV(-), HCV-PCR(-), anti-CMV(-), EBV IgM(-), EBV IgG(-), 
FANA(-), anti-smooth muscle Ab(-), anti-mitochondrial Ab(-). 
Iron, TIBC, ceruloplasmin, α-1 antitrypsin and IgG were within 
the normal range. Based on these results we could exclude other 
causes of acute hepatitis. The mean score of Council of Interna-
tional Organizations of Medical Scientists (CIOMS) or RUCAM 
was 8 (range, 6-10).
5. Findings of liver biopsy
Liver biopsy was conducted in 9 individuals during hospital 
stay. One patient progressed to fulminant hepatitis and eventu-
ally received liver transplantation, which enabled us to obtain 
the liver specimen that demonstrated the extent of organ injury. 
Among the 13 individuals in whom liver biopsy was not per-
formed due to rapid clinical improvement or outright refusal 
against the procedure, 1 patient died of rapid progressing hepat-
Fig. 1. The liver biopsy of an alcoholic patient shows focal mild fatty change, the infiltration of many neutrophils and occasional eosinophils, 
apoptotic bodies with bridging necrosis and fibrosis (A, H&E stain, ×200; B, H&E stain, ×400).496  Gut and Liver, Vol. 5, No. 4, December 2011
ic failure. Of 2 patients with alcoholic liver disease, liver biopsy 
was conducted in one patient which demonstrated periportal 
and perivenular neutrophilic infiltration, fatty change, apoptotic 
body, bridging necrosis and fibrosis, indicative of toxic hepatitis 
mixed with alcoholic hepatitis (Fig. 1). The histological find-
ings of the remaining 8 patients demonstrated inflammatory 
cell infiltration, necrosis of hepatic cells and mild to moderate 
cholestasis consistent with drug or toxin induced acute hepatitis 
(Fig. 2). The patient who received liver transplantation showed 
diffuse necrosis of hepatic cells (Fig. 3). 
6. Clinical course
Patients ceased taking P. multiflorum Thunb upon hospital 
admission. Twenty three patients showed gradual improvement 
of liver function, although one patient had progressed to fulmi-
nant hepatitis and subsequently received liver transplantation. 
Another one patient with underlying alcoholic liver cirrhosis 
died of acute hepatic failure with rapid clinical deterioration. 
The mean hospital stay of patients was 20 days.
One patient (case 1) had taken one bottle of Soju (360 cc) 
daily for 20 years, which had about 20 percent alcohol content, 
who had ceased alcohol intake 3 months prior to hospitalization. 
He rapidly progressed to hepatic failure after hospitalization, 
and on the fourth day of admission brain computed tomogra-
phy demonstrated hepatic encephalopathy and cerebral edema. 
He refused liver transplantation and then developed acute renal 
failure on the eighth day of admission and died on the 13th day 
of admission (Fig. 4A). As the patient had ceased alcohol intake 
3 months prior to hospitalization before the intake of P. multi-
florum Thunb, it is reasonable to conclude that the direct cause 
of liver injury was the plant, not the alcohol. It is also reason-
able to assume that patients with underlying alcoholic liver cir-
rhosis have worse outcomes in drug induced liver injuries. We 
previously reported case 5,
15 a 34-year-old man (case 5) who 
was diagnosed with reactivation of pulmonary tuberculosis in 
association with immunosuppression caused by P. multiflorum 
Fig. 2. Microscopic examination shows lobular portal inflammation with cholestasis and hepatocyte damage (A, H&E stain, ×200; B, H&E stain, 
×400).
Fig. 3. (A) The cut surface of the explanted liver shows slight nodularity and a brownish-tan color change. (B) Microscopic findings demonstrate 
massive hepatocellular necrosis (H&E stain, ×100).Jung KA, et al: Hepatotoxicity of Polygonum multiflorum Thunb  497
Thunb. A 62-year-old man (case 10) who was warfarinized due 
to cerebral infarction and atrial fibrillation had well-controlled 
INR in the range between 2 and 3 prior to hospitalization. A 
severely prolonged prothrombin time, an INR of 14.98, were 
noted on admission, it was rapidly improving after he stopped 
taking warfarin. This case showed the potential herb-drug inter-
action between the P. multiflorum Thunb and warfarin (Fig. 4B). 
A 24-year-old man (case 12), who had been healthy, drank tea 
boiled with P. multiflorum Thunb for approximately 1 month in 
addition to taking some folk remedies was admitted with acute 
liver failure. He was subsequently transferred to the liver trans-
plantation center for receiving a liver transplant. The patient 
in case 18 is the wife of the patient in case 15, had a history 
of P. multiflorum Thunb ingestion. She was recommended to 
undergo a liver function test and diagnosed with asymptomatic 
hepatitis. She stopped taking P. multiflorum Thunb, and then 
her liver function test improved. 
We put a premium on the patient in case 19, who developed 
liver injury by rechallenge of P. multiflorum Thunb (Fig. 5). In 
other words he had a past medical history of DILI associated 
with P. multiflorum Thunb 10 months previously. Even though 
he took a single dose of P. multiflorum Thunb this time, he 
presented with myalgia with markedly elevated serum transami-
nase. His liver function showed rapid improvement after ceasing 
P. multiflorum Thunb intake. 
DISCUSSION
DILI is defined as biochemical injury to the liver proven to be 
caused by intake of a drug within the previous three months. 
The diagnosis is established when other causes of the liver 
disease are excluded. DILI is characterized by the tendency to 
improve following discontinuation of the offending drug, which 
recurs after recommencement.
21,22 However, the study of DILI is 
still difficult and controversial due to its lack of the reliability 
of serologic or histological tests to make a definite diagnosis. 
The articles recently reported showed unsatisfactory results re-
garding the reliability of RUCAM.
23 A comparative study with 
respect to expert opinions and RUCAM revealed that the former 
was better in the diagnostic concordance.
24 However, we do 
not have many researches to support this yet. Until now the 
most important method to make a diagnosis of DILI is to rule 
out other causes of liver injury for the patients with a history 
of medications or herbal medicines that have hepatotoxicity. 
Like the preceding diagnosis of DILI was based on the author’s 
opinions and the RUCAM scale, and thus some controversy still 
exists in this study. 
Fig. 4. Changes in clinical parameters and characteristic findings during the hospital course of case 12 (A) and case 15 (B). 
ALT, alanine aminotransferase; TB, total bilirubin; PT, prothrombin time; PMT, Polygonum multiflorum Thunb. 
Fig. 5. This figure shows 2-fold markedly elevated aminotransferase 
levels  following exposure to the same substance and rapid recovery 
immediately after the patient stopped taking it (case 19). 
ALT, alanine aminotransferase; TB, total bilirubin; PMT, Polygonum 
multiflorum Thunb.498  Gut and Liver, Vol. 5, No. 4, December 2011
As interests in health grows, herbal preparations and plants 
become widely consumed by people all over the world, includ-
ing Korea.
25,26 Polygonaciae is generally known to be safe and 
not all who consume it develop liver injury. The patients en-
rolled in this study were symptomatic and were examined medi-
cally, except for one patient. In most cases of asymptomatic 
hepatitis following ingestion of P. multiflorum Thunb, as evi-
denced in case 18, the patients did not seek medical consulta-
tion. Considering those event of asymptomatic or mild hepatitis, 
the frequency of liver injury caused by P. multiflorum Thunb is 
expected to be high. The main constituents of Shou-Wu-Pain 
are polyphenols and anthraquinones - the latter is metabolized 
into anthrones and absorbed in the gastrointestinal tract, which 
can induce liver damage.
13,15,17,27,28 To date, there are 6 case re-
ports of P. multiflorum Thunb-induced hepatotoxicity
14,15,17-20 
although the mechanism of P. multiflorum Thunb-induced 
hepatotoxicity is still unclear. Most of the patients recovered 
their liver function with conservative management. Our patients 
consumed the root of P. multiflorum as the different forms in-
cluding tea, liquor or powder. There existed a broad spectrum 
of their clinical course: from asymptomatic state to fulminant 
hepatitis and death. Unlike previous reports, our cases were dif-
ferent in that P. multiflorum Thunb was consumed in its natural 
form and not having been processed or blended with other 
ingredients. Therefore, the causality between P. multiflorum 
and hepatotoxicity was relatively clear. In this study we also 
checked the CIOMS/RUCAM research using causality assess-
ment
26 in all our patients, the results indicated that our patients 
were probable to definite DILI.
The patients had a history of having ingested P. multiflorum 
Thunb in various forms; tea boil with P. multiflorum Thunb, 
liquor made of P. multiflorum Thunb, honey soaked out with 
P. multiflorum Thunb, and the powder of dried P. multiflorum 
Thunb. However, it is assumed that the form of intake has no 
relation to the severity of hepatotoxicity. The type of liver in-
jury on the basis of laboratory findings at the time of diagnosis 
was hepatocellular in 18 patients. The histological findings were 
consistent with toxic hepatitis in 7 out of 9 individuals in whom 
liver biopsy was performed, with the exception of 2 patients 
whose specimen demonstrated toxic hepatitis mixed with alco-
holic hepatitis. Although only a few cases existed, given that 
the clinical course was aggravated by markedly prolonged pro-
thrombin time following concurrent administration of P. multi-
florum and warfarin, we cautiously suggest that P. multiflorum 
might interact with alcohol and/or warfarin. The potential for 
herb-drug interaction as well as DILI should also be consid-
ered.
11 
Given that liver injury was dose-independent and the time 
interval from P. multiflorum Thunb intake to clinical mani-
festation was short in some patients, there might be different 
opinions about their diagnosis. But, authors presume that the 
mechanism of P. multiflorum Thunb-induced liver injury is id-
iosyncratic liver injury even though we cannot assure you that 
our anticipation is absolutely true owing to the lack of data. The 
patient in case 19 had no history of previous chronic disease of 
other organs including the liver and had a history of hepatitis 
caused by the same substance one year before. He complained 
only myalgia without associated gastrointestinal symptoms just 
after another exposure to P. multiflorum Thunb and his liver 
function test showed hepatocelluar pattern with normal muscle 
enzyme. But, he made a rapid recovery after the discontinuation 
of P. multiflorum Thunb intake. Authors judged that this infor-
mation supported the correlation between P. multiflorum Thunb 
and liver injury in case 19 which also carried an important 
thing as a rechallenge case. 
Herbal preparations and dietary supplements are widely con-
sumed in many countries under the assumption that they are 
natural and therefore safe.
13,19,29 Consumers are unaware that 
they can potentially be hazardous to their health. As P. multiflo-
rum Thunb is one of them, this study highlights the seriousness 
of its hepatotoxicity and reminds us of the fact that consum-
ers tend to place undue emphasis on the perceived benefits of 
herbal preparations while neglecting their potential toxicities. 
P. multiflorum Thunb has been also favorably advertised on the 
Internet and the printed media, and being actively cultivated in 
lots of places. 
Our study is worthy of notice for 3 main reasons. First, the 
patient in case 19 is all the more meaningful in that it can be a 
direct evidence for the causal relationship between liver injury 
and P. multiflorum Thunb. Second, even worse, many of our 
patients expressed their wish to continue consuming herbal 
preparations in the future. In other words, the repeated con-
sumption of P. multiflorum Thunb is just as problematic as the 
liver injuries it caused. Third, the age of the enrolled patients 
ranged between 24 and 65 (median, 48), a relatively young 
generation. During hospital stay, the youngest patient received 
a liver transplant and another one eventually died from liver 
failure, which implies that there is a social context behind the 
use of P. multiflorum Thunb. 
In summary, this study was derived from the author’s expe-
riences of managing liver injuries induced by P. multiflorum 
Thunb in 25 patients who followed various clinical courses, 
from an absence of symptom to death. Previous reports showed 
comparatively mild clinical courses with a handful of cases, 
while this study was based on a variety of cases pertaining to a 
single herb experienced in a single center. For this reason, this 
study is significant when it comes to establishing the causality 
between P. multiflorum Thunb and hepatotoxicity. To over-
come diagnostic limitation, a new diagnostic guideline which 
minimizes the interobserver variability and has a good reliabil-
ity urgently needs to be established. In conclusion, our study 
demonstrated an association between P. multiflorum Thunb 
and hepatotoxicity. As the increasing interests in botanical and 
nutritional supplements, we need to have systematic studies to Jung KA, et al: Hepatotoxicity of Polygonum multiflorum Thunb  499
identify the potential toxicities of those products and educate 
the general public from their harmful effects.
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